Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission (vol 62, pg 765, 2012)

被引：0
|
作者：
Tanahashi, Shunsuke [1 ]
Yamamura, Satoshi [1 ]
Nakagawa, Masanori [1 ]
Motomura, Eishi [1 ]
Okada, Motohiro [1 ]
机构：
[1] Mie Univ, Brain Sci & Anim Model Ctr BSAM, Grad Sch Med, Dept Psychiat, 2-174 Edobashi, Tsu, Mie 5148507, Japan
来源：
NEUROPHARMACOLOGY | 2019年 / 148卷
关键词：
D O I：
10.1016/j.neuropharm.2018.11.001
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [41] Bifeprunox:: A novel atypical antipsychotic sharing dopamine D2 receptor partial agonism and serotonin 5-HT1A receptor agonism
    Marquis, KL
    Hertel, P
    Reindeers, JH
    van der Neut, M
    Ronken, E
    Hesselink, MB
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 305 - 305
  • [42] SLV313 is a dopamine D2 receptor antagonist and serotonin 5-HT1A receptor agonist:: In vitro and in vivo neuropharmacology
    Glennon, J
    McCreary, AC
    Ronken, E
    Siarey, R
    Hesselink, MB
    Feenstra, R
    Van Vliet, B
    Long, SK
    Kruse, CG
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S277 - S277
  • [43] In vivo pharmacology of novel antipsychotics with diverse dopamine D2 and serotonin 5-HT1A properties: Evidence for lowered EPS liability
    Kleven, MS
    Barret-Grevoz, C
    Newman-Tancredi, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S437 - S437
  • [44] Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats
    Auclair, Agnes L.
    Galinier, Alexandra
    Besnard, Joel
    Newman-Tancredi, Adrian
    Depoortere, Ronan
    PSYCHOPHARMACOLOGY, 2007, 193 (01) : 45 - 54
  • [45] Estrogen Treatment Blocks 8-Hydroxy-2-dipropylaminotetralin- and Apomorphine-Induced Disruptions of Prepulse Inhibition: Involvement of Dopamine D1 or D2 or Serotonin 5-HT1A, 5-HT2A, or 5-HT7 Receptors
    Gogos, Andrea
    Kwek, Perrin
    Chavez, Carolina
    van den Buuse, Maarten
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01): : 218 - 227
  • [46] Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats
    Agnès L. Auclair
    Alexandra Galinier
    Joël Besnard
    Adrian Newman-Tancredi
    Ronan Depoortère
    Psychopharmacology, 2007, 193 : 45 - 54
  • [47] Affinity and efficacy at dopamine D2 and serotonin 5-HT1A receptors of novel antipsvchotic agents:: G-protein activation in native rat brain membranes
    Cosi, C
    Leduc, N
    Assié, M
    Newman-Tancredi, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S438 - S439
  • [48] Repeated Clozapine Increases the Level of Serotonin 5-HT1AR Heterodimerization with 5-HT2A or Dopamine D2 Receptors in the Mouse Cortex
    Szlachta, Marta
    Kusmider, Maciej
    Pabian, Paulina
    Solich, Joanna
    Kolasa, Magdalena
    Zurawek, Dariusz
    Dziedzicka-Wasylewska, Marta
    Faron-Gorecka, Agata
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [49] Actions of Novel Antipsychotic Agents on Apomorphine-Induced PPI Disruption: Influence of Combined Serotonin 5-HT1A Receptor Activation and Dopamine D2 Receptor Blockade
    Agnès L Auclair
    Mark S Kleven
    Joël Besnard
    Ronan Depoortère
    Adrian Newman-Tancredi
    Neuropsychopharmacology, 2006, 31 : 1900 - 1909
  • [50] Anatomical relationships between serotonin 5-HT2A and dopamine D2 receptors in living human brain
    Ishii, Tatsuya
    Kimura, Yasuyuki
    Ichise, Masanori
    Takahata, Keisuke
    Kitamura, Soichiro
    Moriguchi, Sho
    Kubota, Manabu
    Zhang, Ming-Rong
    Yamada, Makiko
    Higuchi, Makoto
    Okubo, Yoshinori
    Suhara, Tetsuya
    PLOS ONE, 2017, 12 (12):
12345